Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Inventory (2016 - 2025)

Historic Inventory for Tandem Diabetes Care (TNDM) over the last 14 years, with Q3 2025 value amounting to $137.3 million.

  • Tandem Diabetes Care's Inventory fell 994.29% to $137.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $137.3 million, marking a year-over-year decrease of 994.29%. This contributed to the annual value of $149.6 million for FY2024, which is 527.11% down from last year.
  • Per Tandem Diabetes Care's latest filing, its Inventory stood at $137.3 million for Q3 2025, which was down 994.29% from $142.6 million recorded in Q2 2025.
  • Over the past 5 years, Tandem Diabetes Care's Inventory peaked at $161.7 million during Q2 2024, and registered a low of $65.7 million during Q3 2021.
  • Over the past 5 years, Tandem Diabetes Care's median Inventory value was $137.3 million (recorded in 2025), while the average stood at $119.5 million.
  • As far as peak fluctuations go, Tandem Diabetes Care's Inventory surged by 6753.96% in 2023, and later crashed by 1180.74% in 2025.
  • Tandem Diabetes Care's Inventory (Quarter) stood at $68.6 million in 2021, then skyrocketed by 62.09% to $111.1 million in 2022, then soared by 42.14% to $157.9 million in 2023, then dropped by 5.27% to $149.6 million in 2024, then fell by 8.24% to $137.3 million in 2025.
  • Its last three reported values are $137.3 million in Q3 2025, $142.6 million for Q2 2025, and $141.2 million during Q1 2025.